Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen's PCSK9 outcomes trial to deliver data sooner than expected
Fierce Pharma
Thu, 12/24/15 - 10:34 am
Tags:
Amgen, Repatha, PCSK9 inhibitors
Amgen buys another cancer-fighting virus project in a $10.5M deal
Fierce Biotech
Tue, 12/22/15 - 10:45 am
Tags:
Amgen, Catherex, oncovirus, M&A
Amgen, Inc, Celgene Corporation Can Find Array Biopharma Inc Attractive
Bidness, ETC
Mon, 12/21/15 - 02:57 pm
Tags:
Amgen, Celgene, Array Biopharma
Amgen wins quick EU approval for Imlygic, its first-in-class immuno-oncology drug
Fierce Pharma
Sun, 12/20/15 - 04:32 pm
Tags:
Amgen, Europe, Imlygic, melanoma
Amgen PCSK-9 Prescription Volumes Ahead of Regeneron Pharmaceuticals
Bidness, ETC
Fri, 12/18/15 - 09:09 am
Tags:
Amgen, PCSK9 inhibitors, Regeneron, Sanofi, Repatha, Praluent
4 Top Biotech Stocks for 2016
24/7 Wall St
Fri, 12/18/15 - 08:57 am
Tags:
Roche, Amgen, Bluebird Bio, Valeant Pharmaceuticals
Amgen reacquires rights to three drugs from Glaxo in 48 countries
Yahoo/Reuters
Mon, 12/14/15 - 10:42 pm
Tags:
Amgen, GSK, Prolia, Vectibix, Xgeva
The new PCSK9 scorecard: Praluent favored by UnitedHealth, Repatha by CVS, both by Express Scripts
BioPharma Dive
Fri, 12/11/15 - 10:23 pm
Tags:
PCSK9 inhibitors, Praluent, Repatha, Regeneron, Sanofi, Amgen, Unitedhealth Group, CVS, Express Scripts
Is Amgen's Prolia A Better Drug For Reducing Fractures And Recurrence After Breast Cancer?
Forbes
Fri, 12/11/15 - 11:29 am
Tags:
Amgen, Prolia, breast cancer
Amgen stalls Apotex's Neulasta biosim launch with court victory
Fierce Pharma
Thu, 12/10/15 - 06:44 pm
Tags:
Amgen, Apotex, Neulasta, biosimilars
Why Amgen Can Acquire Galapagos NV?
Bidness, ETC
Wed, 12/9/15 - 09:38 am
Tags:
Amgen, Galapagos, M&A
Amgen and Regeneron Face Declining PCSK-9 Prescription Volumes
Bidness, ETC
Mon, 12/7/15 - 03:02 pm
Tags:
Amgen, Regeneron, PCSK9 inhibitors, Sanofi, Praluent, Repatha
Novartis: Study shows copycat works just as well as Amgen drug
Yahoo/Reuters
Mon, 12/7/15 - 12:10 pm
Tags:
Novartis, Amgen, Neulasta, Sandoz, generics, breast cancer
The 5 pharma vets and 3 newcomers that made BCG's '50 most innovative' firms list
BioPharma Dive
Fri, 12/4/15 - 08:26 pm
Tags:
Gilead Sciences, Biogen, Roche, Bayer, JNJ, Amgen, innovation
Amgen and Merck & Co to Collaborate for Immunotherapy Cancer
Bidness, ETC
Fri, 12/4/15 - 08:19 pm
Tags:
Amgen, Merck, Keytruda, cancer immunotherapy, Blincyto
The 3 Most Important Drugs in Amgen's Pipeline
Motley Fool
Fri, 12/4/15 - 08:17 pm
Tags:
Amgen, ABP 501, Omecamtiv Mecarbil, Kyprolis
Amgen's First Biosimilar Marketing Authorization Application Submitted To European Medicines Agency For ABP 501
Yahoo
Fri, 12/4/15 - 01:40 pm
Tags:
Amgen, biosimilars, Europe, Humira, ABP 501
3 Leaders In Alzheimer's BACE Inhibition
Seeking Alpha
Wed, 12/2/15 - 11:05 am
Tags:
Alzheimer's disease, Amgen, AstraZeneca, BACE inhibitors, Eli Lilly, Merck, Novartis
Repatha Vs. Praluent: Will Amgen's Patents Decide The Race For The Prevailing PCSK9 Inhibitor?
Seeking Alpha
Wed, 12/2/15 - 09:27 am
Tags:
Repatha, Praluent, Amgen, Sanofi, Regeneron, PCSK9 inhibitors, patents
UnitedHealth Unit Favors Sanofi, Regeneron Cholesterol Drug
Bloomberg
Tue, 12/1/15 - 10:16 am
Tags:
Unitedhealth Group, Sanofi, Regeneron, Amgen, Praluent, Repatha

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.